BRPI0407652A - método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição - Google Patents

método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição

Info

Publication number
BRPI0407652A
BRPI0407652A BRPI0407652-4A BRPI0407652A BRPI0407652A BR PI0407652 A BRPI0407652 A BR PI0407652A BR PI0407652 A BRPI0407652 A BR PI0407652A BR PI0407652 A BRPI0407652 A BR PI0407652A
Authority
BR
Brazil
Prior art keywords
composition
active agent
effectiveness
producing
enhancing
Prior art date
Application number
BRPI0407652-4A
Other languages
English (en)
Inventor
Isabelle Hansenne
Marc Cornell
Hani Fares
Peter Foltis
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BRPI0407652A publication Critical patent/BRPI0407652A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO PARA ACENTUAR A EFICáCIA DE UM AGENTE ATIVO, COMPOSIçãO E MéTODO PARA PRODUZIR A COMPOSIçãO". A presente invenção refere-se a composições que contêm pelo menos um derivado de ácido salicílico e pelo menos um agente ativo cosmético, dermatológico, farmacêutico, etc., onde o derivado de ácido salicílico aumenta, acentua, etc., a eficácia do agente ativo, bem com ao métodos de produção e uso de tais composições. A invenção também se refere a um método para acentuar a eficácia de agentes ativos com esses derivados de ácido salicílico.
BRPI0407652-4A 2003-02-19 2004-02-06 método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição BRPI0407652A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/367,700 US8343519B2 (en) 2003-02-19 2003-02-19 Chemical enhancer and method
PCT/EP2004/001169 WO2004073745A1 (en) 2003-02-19 2004-02-06 Salicylic acid derivative as efficacy enhancer and method

Publications (1)

Publication Number Publication Date
BRPI0407652A true BRPI0407652A (pt) 2006-02-21

Family

ID=32850027

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407652-4A BRPI0407652A (pt) 2003-02-19 2004-02-06 método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição

Country Status (5)

Country Link
US (1) US8343519B2 (pt)
EP (1) EP1594546A1 (pt)
JP (1) JP2007523832A (pt)
BR (1) BRPI0407652A (pt)
WO (1) WO2004073745A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161392A1 (en) * 2003-02-19 2004-08-19 L'oreal S.A. Skin peeling composition and method
FR2884416B1 (fr) * 2005-04-19 2007-06-15 Oreal Utilisation comme actif deodorant d'un derive lipophile de l'acide salicylique dans une composition deodorante ne contenant pas d'agent antitranspirant ; procede de traitement des odeurs corporelles
WO2007031117A1 (en) * 2005-04-19 2007-03-22 L'oreal Use op a lipophilic salicylic acid derivative as a deodorant active agent, process for treating body odour
FR2884417B1 (fr) 2005-04-19 2007-06-15 Oreal Composition cosmetique deodorante comprenant 'association d'un derive lipophile de l'acide salicylique et d'un sel d'aluminium anti-transpirant
US20070025939A1 (en) * 2005-07-29 2007-02-01 L'oreal S.A. cosmetic compositions containing hydroquinone and various sunscreen agents
KR20090004980A (ko) * 2006-04-18 2009-01-12 디에스엠 아이피 어셋츠 비.브이. 살리실산 및 아스코브산을 포함하는 화장품 조성물
US20080082058A1 (en) * 2006-10-02 2008-04-03 Wallach Gary S Debriding Callus Foot Tissue
US8562574B2 (en) * 2006-10-02 2013-10-22 Gary S. Wallach Callus-tissue-debridement apparatus
CN101754765B (zh) * 2007-07-20 2013-04-17 乐敦制药株式会社 乳液组合物
FR2936705B1 (fr) 2008-10-08 2010-12-17 Oreal Procede de rasage utilisant des derives de l'acide salicylique
JP5615515B2 (ja) * 2009-05-26 2014-10-29 持田製薬株式会社 洗浄用組成物
FR2990850B1 (fr) * 2012-05-25 2014-05-16 Oreal Composition cosmetique comprenant l'association d'un derive lipophile de l'acide salicylique, d'un sel ou complexe d'aluminium anti-transpirant et d'un sel d'acide amine n,n-diacide acetique
FR3012960B1 (fr) 2013-11-13 2016-07-15 Oreal Utilisation comme agent deodorant d'un derive salifie d'acide salicylique, seul ou en melange
WO2018115058A1 (en) * 2016-12-22 2018-06-28 L'oreal Preserving agent comprising 4-(3-ethoxy-4-hydroxyphenyl)-2-butanone, and use thereof in cosmetic compositions
CN109966241A (zh) * 2019-04-16 2019-07-05 浙江大学 一种促渗组合物在外用制剂经皮促渗中的应用
CN111559962B (zh) * 2020-07-14 2020-10-30 江西中医药大学 一种具有抗氧化活性的新酚酸类化合物的制备方法及应用
US12090224B2 (en) 2021-10-31 2024-09-17 L'oreal Cosmetic composition comprising high amounts of ceramide-np
US12064504B2 (en) 2021-10-31 2024-08-20 L'oreal Cosmetic compositions comprising high amounts of trifluoromethylhenyl valylglycine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581542B1 (fr) * 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
US5389677B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
LU87187A1 (fr) 1988-03-31 1989-10-26 Oreal Association de derives de pyrimidine et de derives d'acide salicylique pour induire et stimuler la croissance des cheveux et diminuer leur chute
LU87408A1 (fr) 1988-12-16 1990-07-10 Oreal Utilisation de derives salicyles pour le traitement du vieillissement de la peau
FR2653336B1 (fr) 1989-10-20 1994-04-08 Oreal Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
BR9001880A (pt) 1990-04-18 1991-11-12 Forjas Taurus Sa Mecanismo de desarme do cao aplicavel a pistolas semi-automaticas
DE69321285T2 (de) 1992-05-15 1999-03-04 Shiseido Co. Ltd., Tokio/Tokyo Äusserliches Hautpräparat
US5516793A (en) * 1993-04-26 1996-05-14 Avon Products, Inc. Use of ascorbic acid to reduce irritation of topically applied active ingredients
FR2714599B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition pour lutter contre le vieillissement, agissant siimultanément sur les couches superficielles et profondes de la peau, son utilisation.
FR2714831B1 (fr) 1994-01-10 1996-02-02 Oreal Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé de solubilisation de ces dérivés.
FR2718640B1 (fr) 1994-04-18 1996-05-15 Oreal Composition cosmétique et/ou dermatologique notamment pour dépigmenter la peau, ses utilisations.
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
FR2726468B1 (fr) 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
US5687971A (en) 1995-07-07 1997-11-18 Wascana Gaming Inc. Bingo game management method
FR2740040B1 (fr) 1995-10-23 1997-12-05 Oreal Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p
US6159479A (en) 1997-09-16 2000-12-12 L'oreal Hydrous salicylic acid solutions
FR2768622B1 (fr) 1997-09-22 1999-11-26 Oreal Extrait de rosacees en tant qu'antagoniste de bradykinine
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
DE60028794T2 (de) 1999-09-06 2007-05-24 Ueda, Setsuko Chemisches Schälmittel
US6566020B2 (en) * 2001-04-27 2003-05-20 Advanced Micro Devices, Inc. Dark field trench in an alternating phase shift mask to avoid phase conflict

Also Published As

Publication number Publication date
US8343519B2 (en) 2013-01-01
US20040162272A1 (en) 2004-08-19
JP2007523832A (ja) 2007-08-23
WO2004073745A1 (en) 2004-09-02
EP1594546A1 (en) 2005-11-16

Similar Documents

Publication Publication Date Title
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
BRPI0409516A (pt) composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico
ES2176502T3 (es) Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
BR0207726A (pt) Sais farmacêuticos
BR0007430A (pt) Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
NO20052494D0 (no) Preparater inneholdende melatonin, gingko biloba og biotin.
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
BR0311222A (pt) R-enantiÈmeros de derivados de piranoindol contra hepatite c, seu método de obtenção e composição farmacêutica compreendendo os mesmos
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
BRPI0611526A2 (pt) composição tópica contendo gelatina
GT200400134A (es) Sistemas emulsionantes que contienen derivados de azetidina
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
BR0312179A (pt) Processo para preparação de derivado de epik5-n-o-supersulfato, composição farmacêutica e composição cosmética contendo o mesmo e seu uso
EA200100853A1 (ru) Резорциновая композиция
DE60231385D1 (de) Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung
DE60217292D1 (de) Veterinärmedizinische dermatologische zusammensetzung
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
EA200400709A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15V Prolongation of time limit allowed

Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E CONCEDIDO A DEVOLUCAO DE PRAZO DE 47 DIAS , NOS TERMOS DO ARTIGO 221 2O DA LPI E DA RESOLUCAO 116/04.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 10A E 11A ANUIDADES.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/67 (2006.01), A61K 8/34 (2006.01), A61K 8/3